InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Leuthner Brian A, Chairman & CEO. Director active across 1 companies, notably ONCOSEC MEDICAL Inc. In total, 2 reports have been published. The latest transaction was filed on 28 June 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
0192,000 shares0
Common Stock
SEC:0001493152-21-015620·
0192,000 shares0
Common Stock
SEC:0001493152-21-015620:0·
2 of 2 declarations
About Leuthner Brian A
Brian A. Leuthner is the Interim CEO of ONCOSEC MEDICAL Inc. He is responsible for the strategic direction of the company, which focuses on developing innovative cancer treatments. His role includes overseeing daily operations and working closely with the board to achieve the company's objectives. Brian brings significant experience in the medical sector, contributing to the advancement of treatment technologies. He is committed to furthering ONCOSEC's mission to improve outcomes for cancer patients.
